Altria vs. Philip Morris: One Dividend Is a Trap — Here’s Which One to Avoid

Altria (NYSE:MO | MO Price Prediction) and Philip Morris International (NYSE:PM) both reported full-year 2025 earnings, exposing a widening gulf between two companies that once shared the same corporate DNA.

Philip Morris is executing a credible transformation; Altria is defending a shrinking core while absorbing costly failures. The dividend headline looks attractive for both, but the stories underneath differ sharply.

NJOY Collapses While IQOS and ZYN Keep Climbing

Philip Morris delivered genuine momentum. Full-year revenue surpassed $40 billion, with close to $17 billion generated by the smoke-free business. Smoke-free products now represent 41.5% of total net revenues.

ZYN, the nicotine pouch brand acquired through Swedish Match, shipped 196 million cans in Q4 alone, up 19% year over year. IQOS heat-not-burn volumes grew 12% in Q4, and VEEV e-vapor volumes more than doubled for the full year.

Altria moved in the opposite direction. The company took $2.2 billion in total non-cash impairment charges on NJOY in 2025, and the NJOY ACE device now faces an ITC exclusion order making a U.S. comeback in 2026 essentially impossible.

The on! nicotine pouch brand grew within a growing category but lost share, falling to 16.7% of the pouch market, down 2.3 points. Marlboro saw domestic cigarette volume fall 10.0% for the full year, and full-year share slipped to 40.5%, down 1.2 points.

One Is Transforming. One Is Maintaining.

Philip Morris restructured its entire organization in January 2026 into three segments: International Smoke-Free, International Combustibles, and U.S. This signals leadership fully committed to transition.

The company targets 6%-8% organic revenue growth and 9%-11% adjusted EPS growth on a CAGR basis through 2028. No share repurchases are planned for 2026 as management focuses on reducing leverage toward a net debt to adjusted EBITDA target of approximately 2.0x by year-end.

Altria manages a slower, defensive transition. The company leans on Marlboro’s pricing power and returns capital aggressively. It returned $8 billion to shareholders in 2025 through dividends and buybacks, which is impressive for a business of its size.

But with NJOY sidelined and on! losing ground, the path to meaningful smoke-free revenue remains unclear. A pending CEO transition adds uncertainty heading into 2026.

The Dividend Question

Altria’s yield looks compelling. At a current price of $67.38 against an annualized dividend of $4.24 per share, the yield works out to roughly 6.3%. Philip Morris yields closer to 3.7% at $160.45 with an annualized payout of $5.88 per share. But yield alone does not determine quality.

Altria’s free cash flow covered its dividend at 1.30x in fiscal 2025, leaving limited cushion. The company carries negative shareholders’ equity of $3.50 billion, and insider activity through early 2026 shows no discretionary buying.

Philip Morris carries negative shareholders’ equity of $8.028 billion, but its operating cash flow of $12.23 billion for the full year provides far more coverage against its dividend obligation.

The Stronger Position

Altria’s 6.3% yield is real and consistent, but a high yield on a shrinking business with limited product optionality deserves scrutiny. The on! pouch losing category share despite a growing market is a warning sign.

Philip Morris is not cheap. The forward multiple reflects genuine growth expectations. But the smoke-free transition already produces revenue at scale, the dividend grew 8.9% in 2025, and guidance calls for 11.1%-13.1% adjusted EPS growth in 2026.

Philip Morris carries stronger growth credentials: smoke-free revenue already at scale, an 8.9% dividend increase in 2025, and guidance calling for 11.1%-13.1% adjusted EPS growth in 2026.

Altria pays reliably but carries execution risk with limited product optionality and a smoke-free portfolio still searching for traction. Between the two, the dividend attached to a business still searching for its next act looks like the trap.